Clinical Trials | December 13, 2022
Moderna and Merck announce personalized mRNA cancer vaccine
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
They also released the Operational Guidelines for Wellness activities at AB-HWCs
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
More women centric initiatives being the need of the hour for holistic development
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
The company is focussed on increasing the capacity utilizations while controlling costs
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Subscribe To Our Newsletter & Stay Updated
